POSITRON CORP (POSC) research
POSITRON CORP- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.72
- As of
POSITRON CORP (POSC): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-02.
As of . Source: SEC EDGAR filings for POSC. Method and limitations.
Share the POSC intelligence card
See the full POSC dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for POSC on one page. Preview it with sample data, then open it live with a free account.
Preview the POSC dossierActive signals for POSC
- mediumEARNINGS_MISS
Q3-1995: Missed consensus by 128.8% - EPS $-168 vs $-73.44 estimate
- mediumEARNINGS_MISS
Q1-1996: Missed consensus by 458.8% - EPS $-228 vs $-40.8 estimate
- mediumEARNINGS_MISS
Q4-1998: Missed consensus by 55.4% - EPS $20 vs $44.88 estimate
- mediumEARNINGS_MISS
Missed consensus by 128.8% - EPS $-168 vs $-73.44 estimate
- mediumEARNINGS_MISS
Missed consensus by 458.8% - EPS $-228 vs $-40.8 estimate
FREE, NO ACCOUNT
Every signal on POSC, as it fires
You are seeing 5 of 6 signals recorded on POSC since 2026-05-24.
The five above landed across 2 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, POSC
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
POSC against its peers
POSC's operating margin of -2275.1% ranks in the 15th percentile of 23 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | POSC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 461452 USD | 32.0M USD | 15 | 23 |
| Gross margin | -458.2% | 58.1% | 3 | 18 |
| Operating margin | -2275.1% | -47.6% | 15 | 23 |
| Net margin | -2297.8% | -48.4% | 10 | 23 |
| Return on equity | -734.4% | -70.9% | 3 | 19 |
Peers (23): MYO, MDNC, OM, TELA, RPID, COCH, MDAI, XTNT, NNOX, ZOMDF, SRTS, SERA, LUNG, LNSR, CVRX, SNWV, HYPR, ECOR, PAVM, ELUT, QTI, ARAY, APYX. Left out: RTGN (no annual filing), TLTFF (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (POSC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more POSC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to POSCand get the insider, 13F, options, and confluence read in one view.